$8.47
-0.05-0.59%
Last update: Oct 30, 6:03 PM
BioCryst Pharmaceuticals Inc (BCRX) Stock Price, Quote, News & History
BCRXNASDAQ
Bank of America upgrades Pharvaris to Buy with a new price target, citing reduced clinical risk for deucrictibant in hereditary angioedema despite market...
You can purchase shares of BioCryst Pharma (NASDAQ:BCRX) through any online brokerage.
Other companies in BioCryst Pharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
BioCryst Pharma has a consensus price target of $20.71.
The stock price for BioCryst Pharma (NASDAQ: BCRX) is $8.41 last updated October 30, 2026 at 6:03 PM EDT.
There are no upcoming dividends for BioCryst Pharma.
BioCryst Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for BioCryst Pharma.
BioCryst Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple...
